Cannabinoids for Children: Medical Evidence Reviewed
Cannabinoids for children medical evidence shows promise, especially for treatment-resistant epilepsy. This review synthesizes clinical trials and observational data. Parents and clinicians should consider pharmaceutical cannabinoids carefully.
With Hemp Rules Tightening, Users Worry About Access to THC-Infused Products
Hemp-derived THC regulations are tightening, causing concern among users about continued access to THC-infused products. These regulatory changes impact patient safety and clinical management. Clinicians must stay informed to guide patients through…
Medical Cannabis Bill Adds Vaping, Insomnia for Georgia Patients – State Affairs Pro
The medical cannabis vaping insomnia bill in Georgia allows clinicians to recommend vaping for patients with severe insomnia. This expands treatment options beyond smoking and may improve adherence and lung health. Clinicians should understand vaping…
House Passes Bill to Ease Access to Georgia’s Medical Cannabis Program
The new medical cannabis program bill in Georgia aims to ease patient access by reducing regulatory barriers. This streamlined access could increase patient requests for cannabis recommendations. Clinicians should familiarize themselves with the updated…
Texas Hemp Rules to Ban Smokable Products by End of March
Texas hemp smokable ban introduces new total THC calculation rules affecting product sales by March 2026. Clinicians must counsel patients on the psychoactive risks of smokable hemp products. This regulatory change impacts patient access and clinical…
Research News Roundup: March 12, 2026 – Partnership to End Addiction
This research highlights resident attitudes toward cannabis-free policies in permanent supportive housing. Understanding these attitudes is crucial for clinicians managing substance use and housing stability. The findings inform harm reduction approaches…
In the Mix: 7 More Articles — March 12, 2026
This article reviews cannabis regulatory uncertainty and its clinical implications. It highlights tax disputes and illicit market challenges affecting patient access. Clinicians must navigate these complexities to ensure safe cannabis medicine.
TruAge CEO Stephanie Sikorski Joins CSP C-Store Cannabis Board
Cannabis retail access convenience stores are expanding, increasing patient accessibility to cannabis products. TruAge CEO Stephanie Sikorski joins the CSP C-Store Cannabis Board to advocate for regulatory frameworks. This shift raises clinical concerns…
Recall of Low-Dose Vapes and Pre-Rolls Due to Mislabeled THC Content
Mislabeled THC products have been recalled due to containing higher THC levels than labeled, posing safety risks. Accurate THC dosing is critical for patient safety and symptom management. Clinicians advise verifying third-party testing before cannabis…
Oklahoma House Rejects Bill Expanding Marijuana Employment Ban
Oklahoma medical marijuana employment protections remain intact after the House rejected a bill seeking to expand the marijuana usage ban at work. This decision safeguards patients legally prescribed cannabis from employment discrimination. Clinicians…
